mifepristone has been researched along with 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 12 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, CL; Kelly, PA; Ormandy, CJ; Sutherland, RL | 1 |
| Lee, CS; Musgrove, EA; Sutherland, RL | 1 |
| Beery, R; Bella, R; Geier, A; Lunenfeld, B | 1 |
| Beery, R; Bella, R; Geier, A; Haimsohn, M; Lunenfeld, B | 1 |
| Coutts, A; Murphy, LC; Murphy, LJ | 1 |
| Falkay, G; Földesi, I; Kovács, L | 1 |
| Musgrove, EA; Sutherland, RL | 1 |
| Lynch, M; Martin, JH; van den Berg, HW | 1 |
| Hamilton, JA; Lee, CS; Musgrove, EA; Sutherland, RL; Sweeney, KJ; Watts, CK | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 1 |
| Bigsby, RM; Young, PC | 1 |
| Brouwer, A; Kuil, CW; van der Burg, B; van der Saag, PT | 1 |
| Borras, M; Lacroix, M; Leclercq, G; Legros, N | 1 |
| Ackerman, WE; Kniss, DA; Lockwood, CJ; Mesiano, S; Schatz, F; Summerfield, TL | 1 |
14 other study(ies) available for mifepristone and 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione
| Article | Year |
|---|---|
Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells.
Topics: Androgens; Breast Neoplasms; Dihydrotestosterone; Female; Gene Expression Regulation; Humans; Mifepristone; Pregnenediones; Receptors, Prolactin; RNA, Messenger; Tumor Cells, Cultured | 1992 |
Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.
Topics: Blotting, Northern; Breast Neoplasms; Cell Cycle; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Kinetics; Mifepristone; Pregnenediones; Progesterone Congeners; Proto-Oncogene Mas; Proto-Oncogene Proteins c-fos; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1991 |
Comparison of the physical properties of the nuclear progesterone receptor, bound to antiprogestin RU 486 or progestin ORG 2058, following limited proteolysis.
Topics: Cell Line; Cell Nucleus; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Micrococcal Nuclease; Mifepristone; Molecular Weight; Peptide Fragments; Pregnenediones; Progesterone Congeners; Receptors, Progesterone; Trypsin | 1990 |
Differences in the association of the progesterone receptor ligated by antiprogestin RU38486 or progestin ORG 2058 to chromatin components.
Topics: Cell Line; Centrifugation, Density Gradient; Chromatin; Chromatography, Gel; Cross-Linking Reagents; Estrenes; Imidoesters; Micrococcal Nuclease; Mifepristone; Molecular Weight; Pregnenediones; Progesterone Congeners; Progestins; Receptors, Progesterone | 1987 |
Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens.
Topics: Breast Neoplasms; Carrier Proteins; Culture Media, Conditioned; Dexamethasone; Estradiol; Estrogen Antagonists; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Protein 5; Medroxyprogesterone Acetate; Mifepristone; Neoplasm Proteins; Polyunsaturated Alkamides; Pregnenediones; Progesterone; Progestins; Tumor Cells, Cultured | 1994 |
[Pharmacokinetics of RU 486 and its active metabolites in humans].
Topics: Female; Humans; Metabolic Clearance Rate; Mifepristone; Models, Biological; Myometrium; Pregnenediones; Progesterone Congeners; Radioligand Assay; Receptors, Progesterone; Tissue Distribution; Tritium | 1994 |
Effects of the progestin antagonist RU 486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes.
Topics: Breast Neoplasms; Cell Cycle; Cyclin D1; Cyclins; Dose-Response Relationship, Drug; Estradiol; Humans; Mifepristone; Oncogene Proteins; Polyunsaturated Alkamides; Pregnenediones; Progesterone Congeners; Progestins; Proto-Oncogene Proteins c-myc; RNA, Messenger; S Phase; Tumor Cells, Cultured | 1993 |
The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.
Topics: Binding, Competitive; Breast Neoplasms; Dexamethasone; Down-Regulation; Female; Gonanes; Humans; Medroxyprogesterone Acetate; Mifepristone; Mitosis; Pregnenediones; Progesterone Congeners; Progestins; Receptors, Glucocorticoid; Receptors, Progesterone; Tumor Cells, Cultured | 1993 |
Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
Topics: Breast Neoplasms; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Cyclins; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, myc; Growth Substances; Histones; Humans; Insulin; Kinetics; Mifepristone; Polyunsaturated Alkamides; Pregnenediones; Progesterone Congeners; Protein Kinases; Protein Serine-Threonine Kinases; Recombinant Proteins; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 1993 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Progesterone and dexamethasone inhibition of uterine epithelial cell proliferation: studies with antiprogesterone compounds in the neonatal mouse.
Topics: Animals; Animals, Newborn; Cell Division; Dexamethasone; Epithelial Cells; Epithelium; Female; Hormone Antagonists; In Vitro Techniques; Mice; Mice, Inbred BALB C; Mifepristone; Pregnenediones; Progesterone; Receptors, Glucocorticoid; Receptors, Progesterone; Uterus | 1993 |
Interference between progesterone and dioxin signal transduction pathways. Different mechanisms are involved in repression by the progesterone receptor A and B isoforms.
Topics: Breast Neoplasms; Cytochrome P-450 CYP1A1; Female; Gene Expression Regulation, Enzymologic; Gonanes; Hormone Antagonists; Humans; Mifepristone; Polychlorinated Dibenzodioxins; Pregnenediones; Progesterone Congeners; Receptors, Aryl Hydrocarbon; Receptors, Progesterone; Recombinant Proteins; Signal Transduction; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Up-Regulation | 1998 |
Estrogen receptor-negative/progesterone receptor-positive Evsa-T mammary tumor cells: a model for assessing the biological property of this peculiar phenotype of breast cancers.
Topics: Breast Neoplasms; Cell Division; Cytosol; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Gonanes; Hormone Antagonists; Humans; Mifepristone; Pregnenediones; Progestins; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1997 |
Agonist-Dependent Downregulation of Progesterone Receptors in Human Cervical Stromal Fibroblasts.
Topics: Cervix Uteri; Down-Regulation; Estradiol; Female; Fibroblasts; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Pregnenediones; Receptors, Glucocorticoid; Receptors, Progesterone | 2016 |